| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.28 | 1e-15 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.21 | 1e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |